SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Learning from Failures or Failing to Learn? Lessons from Pharmaceutical R&D
16 references·15 citing·39 second hop
Learning from Failures or Failing to Learn? Lessons from Pharmaceutical R&D (2012)Learning from Failures or Failing to Lear…How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)How to improve R&D productivi…The price of innovation: new estimates of drug development costs (2003)The price of innovation: new …Patents, Citations, and Innovations: A Window on the Knowledge Economy (2002)Patents, Citations, and Innov…The NBER Patent Citation Data File: Lessons, Insights and Methodological Tools (2001)The NBER Patent Citation Data…Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not) (2000)Protecting Their Intellectual…Market Value and Patent Citations: A First Look (2000)Market Value and Patent Citat…Citation Frequency and the Value of Patented Inventions (1999)Citation Frequency and the Va…Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery (1998)Absorptive Capacity, Coauthor…University Versus Corporate Patents: A Window On The Basicness Of Invention (1997)University Versus Corporate P…Modes of Interorganizational Imitation: The Effects of Outcome Salience and Uncertainty (1997)Modes of Interorganizational …The myopia of learning (1993)The myopia of learningA Penny for Your Quotes: Patent Citations and the Value of Innovations (1990)A Penny for Your Quotes: Pate…Organizational Learning (1988)Organizational LearningSectoral patterns of technical change: Towards a taxonomy and a theory (1984)Sectoral patterns of technica…Econometric Models for Count Data with an Application to the Patents-R & D Relationship (1984)Econometric Models for Count …A Behavioral Theory of the Firm. (1964)A Behavioral Theory of the Fi…Reconceptualising innovation failure (2023)Reconceptualising innovation …New Perspectives in Innovation Failure Analysis: A taxonomy of general errors and strategic management for reducing risks (2023)New Perspectives in Innovatio…Does learning from innovation failure enhance innovation performance? A quantitative investigation of small businesses (2023)Does learning from innovation…Divide and conquer: Relating patent quality and value in a conceptual framework based on a systematic review (2023)Divide and conquer: Relating …Trials and Terminations: Learning from Competitors’ R&D Failures (2021)Trials and Terminations: Lear…The endless frontier? The recent increase of R&D productivity in pharmaceuticals (2020)The endless frontier? The rec…Exploring the enabling effects of project management for SMEs in adopting open innovation – A framework for partner search and selection in open innovation projects (2020)Exploring the enabling effect…The financial benefits of persistently high forward citations (2019)The financial benefits of per…Variety in external knowledge sourcing and innovation novelty: Evidence from the KIBS sector in Spain (2017)Variety in external knowledge…Learning from successes and failures in pharmaceutical R&D (2016)Learning from successes and f…Impacts of obstacles on innovation patterns in KIBS firms (2016)Impacts of obstacles on innov…Learning from complex and heterogeneous experiences: the role of knowledge codification (2015)Learning from complex and het…Fostering novelty while reducing failure: Balancing the twin challenges of product innovation (2015)Fostering novelty while reduc…Direct and mediated ties to universities: “Scientific” absorptive capacity and innovation performance of pharmaceutical firms (2015)Direct and mediated ties to u…The economic value of patented inventions: Thoughts and some open questions (2013)The economic value of patente…Can Patents Deter Innovation? The Anticommons in Biomedical Research (1998)The Patent Paradox Revisited: An Empirical Study of Patenting in the U.S. Semiconductor Industry, 1979-1995 (2001)Absorptive Capacity: A Review, Reconceptualization, and Extension (2002)Links and Impacts: The Influence of Public Research on Industrial R&D (2002)Economic Welfare and the Allocation of Resources for Invention (1962)An Evolutionary Theory of Economic Change. (1983)The Resurgence of Regional Economies, Ten Years Later (1995)The Theory of the Growth of the Firm (1995)The Social Shaping of Technology (1996)The entrepreneurial state: debunking public vs. private sector myths (2014)The Structure of Scientific Revolutions (1963)On the mechanics of economic development (1988)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)Dynamic capabilities and strategic management (1997)International Norm Dynamics and Political Change (1998)Deliberate Learning and the Evolution of Dynamic Capabilities (2002)Patent Statistics as Economic Indicators: A Survey (1990)Entrepreneurship in the large corporation: a longitudinal study of how established firms create breakthrough inventions (2001)Market value and patent citations (2005)Technological Innovation, Resource Allocation, and Growth* (2017)Geographic Localization of Knowledge Spillovers as Evidenced by Patent Citations (1993)The Knowledge Economy (2004)Identifying Technology Spillovers and Product Market Rivalry (2013)A Proof for the Queuing Formula: L = λ W (1961)The Goal: A Process of Ongoing Improvement (1984)Can the pharmaceutical industry reduce attrition rates? (2004)Diagnosing the decline in pharmaceutical R&D efficiency (2012)Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018 (2020)Conditional logit analysis of qualitative choice behavior (1972)On the Pooling of Time Series and Cross Section Data (1978)Specification Tests in Econometrics (1978)Aging, Obsolescence, and Organizational Innovation (2000)Simple solutions to the initial conditions problem in dynamic, nonlinear panel data models with unobserved heterogeneity (2005)Competition and Innovation: An Inverted U Relationship (2008)The Increasing Dominance of Teams in Production of Knowledge (2007)Clinical development success rates for investigational drugs (2014)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Toward a knowledge‐based theory of the firm (1996)Psychological Safety and Learning Behavior in Work Teams (1999)
this work references cited by second hop

References

  • 1993The myopia of learning7,467 cited
  • 1988Organizational Learning6,656 cited
  • 1984Sectoral patterns of technical change: Towards a taxonomy and a theory6,106 cited
  • 2003The price of innovation: new estimates of drug development costs4,264 cited
  • 2010How to improve R&D productivity: the pharmaceutical industry's grand challenge3,562 cited
  • 2001The NBER Patent Citation Data File: Lessons, Insights and Methodological Tools3,537 cited
  • 1984Econometric Models for Count Data with an Application to the Patents-R & D Relationship3,391 cited
  • 2000Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not)3,045 cited
  • 1990A Penny for Your Quotes: Patent Citations and the Value of Innovations2,963 cited
  • 1999Citation Frequency and the Value of Patented Inventions1,518 cited
  • 1997Modes of Interorganizational Imitation: The Effects of Outcome Salience and Uncertainty1,249 cited
  • 2002Patents, Citations, and Innovations: A Window on the Knowledge Economy1,222 cited
  • 1997University Versus Corporate Patents: A Window On The Basicness Of Invention1,220 cited
  • 1998Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery1,199 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2000
Market Value and Patent Citations: A First Look
1,095 cited
  • 1964A Behavioral Theory of the Firm.1,092 cited
  • Cited by

    • 2015Fostering novelty while reducing failure: Balancing the twin challenges of product innovation119 cited
    • 2017Variety in external knowledge sourcing and innovation novelty: Evidence from the KIBS sector in Spain109 cited
    • 2021Trials and Terminations: Learning from Competitors’ R&D Failures98 cited
    • 2016Impacts of obstacles on innovation patterns in KIBS firms93 cited
    • 2020Exploring the enabling effects of project management for SMEs in adopting open innovation – A framework for partner search and selection in open innovation projects88 cited
    • 2015Direct and mediated ties to universities: “Scientific” absorptive capacity and innovation performance of pharmaceutical firms83 cited
    • 2020The endless frontier? The recent increase of R&D productivity in pharmaceuticals77 cited
    • 2023Reconceptualising innovation failure64 cited
    • 2023Does learning from innovation failure enhance innovation performance? A quantitative investigation of small businesses54 cited
    • 2023New Perspectives in Innovation Failure Analysis: A taxonomy of general errors and strategic management for reducing risks47 cited
    • 2015Learning from complex and heterogeneous experiences: the role of knowledge codification46 cited
    • 2013The economic value of patented inventions: Thoughts and some open questions45 cited
    • 2016Learning from successes and failures in pharmaceutical R&D24 cited
    • 2023Divide and conquer: Relating patent quality and value in a conceptual framework based on a systematic review16 cited
    • 2019The financial benefits of persistently high forward citations10 cited